Abstract:

The clinical pharmacist plays a crucial role in managing a patient with ischaemic cardiomyopathy (ICM) and heart failure, conducting a thorough review of the patient’s medical and medication history. Notably, the patient had a history of gastrointestinal bleeding and was currently experiencing an acute exacerbation of chronic heart failure. An analysis of the patient’s antithrombotic regimen was performed, and recommendations were made to optimize potassium management and select an appropriate statin during the course of drug administration. We meticulously documented the patient’s daily check-ups, engaging in communication with physicians to acquire empirical knowledge regarding the treatment of heart failure patients with ICM. Furthermore, we diligently focused on details and established comparative links while closely monitoring the medication’s efficacy, safety, and patient compliance. This included a particular emphasis on comparative drug selection, identification, and management of adverse reactions, as well as medication education. Overall, our aim was to provide comprehensive pharmacy services to ensure the safe and effective use of medication by patients.

Key words: Ischemic cardiomyopathy (ICM), Heart failure, Appendage thrombosis, Potassium management, Literature analysis, Clinical pharmacist